Sheffield Bio-Science takes on responsibility for global sales, distribution and development of Girus Life Sciences’ chemically defined Regocel supplements.
“This agreement marks a new dimension for our business as it is our first step into chemically defined supplements,” commented Edmond Scanlon, president of Sheffield Bio-Science, who hopes to reinforce the company’s portfolio by offering animal component free supplements.
Girus say its Regocel supplements are non-nutritional small molecule yield boosters designed to improve cell culture performance by enhancing protein production while maintaining cell viability; this “increases overall bio-manufacturing efficiencies,” providing a novel solution for capacity problems, claim the company.
The supplements are commercially available for use with CHO, Hybridoma, NSO myeloma and stem cells.
“Our customers trust us to deliver innovative, superior products to help them optimise their businesses,” said Scanlon who promises to provide customers of Sheffield Bio-Science with greater access to “the industry’s most innovative and extensive bio-technologies.”